Abstract
The Food and Drug Administration recently cleared silver diamine fluoride for reducing tooth sensitivity. Clinical trials document arrest and prevention of dental caries by silver diamine fluoride. This off-label use is now permissible and appropriate under U.S. law. A CDT code was approved for caries arresting medicaments for 2016 to facilitate documentation and billing. We present a systematic review, clinical indications, clinical protocol and consent procedure to guide application for caries arrest treatment.
MeSH terms
-
Cariostatic Agents / administration & dosage
-
Cariostatic Agents / therapeutic use*
-
Clinical Protocols
-
Dental Caries / prevention & control*
-
Dentin Desensitizing Agents / therapeutic use
-
Fluorides, Topical
-
Humans
-
Off-Label Use / legislation & jurisprudence
-
Quaternary Ammonium Compounds / administration & dosage
-
Quaternary Ammonium Compounds / therapeutic use*
-
San Francisco
-
Silver Compounds
-
Systematic Reviews as Topic
-
Tooth Remineralization / methods
-
United States
-
United States Food and Drug Administration
Substances
-
Cariostatic Agents
-
Dentin Desensitizing Agents
-
Fluorides, Topical
-
Quaternary Ammonium Compounds
-
Silver Compounds
-
silver diamine fluoride